You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤三九(000999.SZ):今年配方顆粒業務預計實現恢復性增長
格隆匯 06-14 07:30

格隆匯6月14日丨華潤三九(000999.SZ)召開電話會議,就“配方顆粒上半年看到復甦勢頭如何,主要來自哪些推動力,今年能否回到國標推行前水平?今年國標推進和備案進度?”

公司回覆稱,今年配方顆粒業務預計實現恢復性增長,並期望下半年隨着國標備案品種數量逐漸增加以及去年同期基數較低有更快速增長。今年業務整體環境要優於去年,配方顆粒業務2022年受省標品種各地備案進度影響,全年表現低於預期,22年底各省備案工作取得一定進展,為23年業務發展奠定了業務基礎。2月1日第四批48箇中藥配方顆粒國家藥品標準正式頒佈,有助於各地備案推進,公司也會加快各地的備案進程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account